---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-004348"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2026-01-14T23:59:59+00:00"
generated_at: "2026-05-16T10:25:33.290354+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BiomX closes private placement, issues 3,300 Series Y Preferred shares; appoints director

## Summary
- Closed private placement of 3,300 Series Y Convertible Preferred shares and warrants on January 13, 2026.
- Board appointed Reuven Yeganeh as Class 1 director, effective at closing; board size increased to nine.
- Yeganeh is CEO of Continual Ltd. and independent under NYSE American rules; since 2024 also director of Nukkleus Inc.
- Company entered into standard indemnification agreement with Yeganeh.

## SEC filing metadata
- accession: 0001213900-26-004348
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2026-01-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 5.02, 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390026004348/0001213900-26-004348-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390026004348/ea027293801-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-004348
- JSON: https://secwatch.observer/filing/0001213900-26-004348.json
- Plain text: https://secwatch.observer/filing/0001213900-26-004348.txt

## Source-grounded claims
- claim_id: 73b2e6fccb7edbcb958cdec74e9e67526000bf86
  claim: BiomX Inc.: Filed Certificate of Designations for Series Y Convertible Preferred Stock, creating a new series of preferred stock with specific rights and preferences (effective 2026-01-13).
  evidence_excerpt: On January 13, 2026, the Company filed a Certificate of Designations of Series Y Convertible Preferred Stock (the “Certificate of Designations”) with the Secretary of State of the State of Delaware
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390026004348/0001213900-26-004348-index.htm
- claim_id: ac44cbec2ec75e14e58f6f4a855708e159af8087
  claim: BiomX Inc. entered into a equity purchase (effective 2026-01-13).
  evidence_excerpt: On January 13, 2026, the Company issued 3,300 shares of the Preferred Stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390026004348/0001213900-26-004348-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.